Mitopure™ (Proprietary Urolithin A) Bioavailability in Healthy Adults

Healthy Clinical Trial

— NOURISH  

Official title:

Open-labelled, Crossover and Randomized Study With Mitopure™ (Proprietary Urolithin A) Dietary Supplementation Compared to Pomegranate Juice Intake: A Bioavailability Study in Healthy Adults (NOURISH)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04160312
• Other study ID #: AFCRO-110 / 19.01.AMZ
• Status: Completed
• Phase: N/A
• Start date: November 8, 2019
• Est. completion date: March 31, 2020

Study information

• Verified date: April 2020
• Source: Amazentis SA
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a single-center, two-period, crossover, randomized, open labelled study enrolling 100 healthy subjects to evaluate the Urolithin A producer status and to compare bioavailabilty of direct dietary supplementation with Mitopure™ (proprietary Urolithin A) to dietary exposure with pomegranate juice

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: March 31, 2020
• Est. primary completion date: February 29, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

1. Males and females 18 to 80 years of age;

2. Is in general good health, as determined by the clinical research team;

3. Willingness to consume investigational product, complete questionnaires and to complete all clinic visits;

4. Have given voluntary, written, informed consent to participant in the study;

Exclusion Criteria:

1. Women who are pregnant, breastfeeding, or planning to become pregnant during the course of the trial;

2. Alcohol or drug abuse within the last 6 months;

3. Volunteers who plan to donate blood during the study or within 30 days of completing the study;

4. Subject has a known allergy to the test material's active or inactive ingredients;

5. Subjects with unstable medical conditions;

6. Clinically significant abnormal laboratory results at screening;

7. Participation in a clinical research trial within 30 days prior to randomization;

8. Allergy or sensitivity to study ingredients; lactose intolerance.

9. Individuals who are cognitively impaired and/or who are unable to give informed consent;

10. Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject.

11. Has taken antibiotics within the previous 30 days;

Related Conditions & MeSH terms

• Healthy
• Healthy Aging

Intervention

Dietary Supplement:
• Mitopure™ (Proprietary Urolithin A)
Fruit flavored sachet containing fixed dose of Mitopure™ (Proprietary Urolithin A)
• Pomegranate Juice
100% Pomegranate juice (approximately 1 glass equivalent)

Locations

Country	Name	City	State
United States	Atlantia Food Clinical Trials CRO (Northwestern University campus)	Chicago	Illinois

Sponsors (2)

Lead Sponsor	Collaborator
Amazentis SA	Atlantia Food Clinical Trials

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Absolute change from T0 to T+24 hours in the Urolithin A (UA) group as compared to Pomegranate Juice (PJ) group in UA- glucuronide plasma levels.		2 days
Secondary	Absolute change from T0 to T+24 hours in the UA group as compared to PJ group in UA- glucuronide blood spot levels		2 days
Secondary	Absolute change from T0 to T+6 hours in the UA group as compared to PJ group in UA- glucuronide plasma levels.		1 day
Secondary	Absolute change from T0 to T+6 hours in the UA group as compared to PJ group in UA- glucuronide blood spot levels.		1 day
Secondary	Change in AUC from T0 to T+6 and/or T+24 in the UA group as compared to the PJ group in UA glucuronide levels		2 days
Secondary	Absolute change from T0 to T6 hours and/or to T24 hours in the UA group as compared to PJ group in UA aglycone (parent) plasma levels		2 days
Secondary	Change in AUC from T0 to T+6 and/or T+24 in the UA group as compared to the PJ group in UA aglycone (parent) plasma levels		2 days
Secondary	Absolute change from T0 to T6 hours and/or to T24 hours in the UA group as compared to PJ group in UA sulfate plasma levels		2 days
Secondary	Change in AUC from T0 to T6 hours and/or to T24 hours in the UA group as compared to PJ group in UA sulfate plasma levels		2 days
Secondary	To assess prevalence of UA producers following consumption of fixed volume of Pomegranate juice in a healthy US population		2 days
Secondary	Differences between UA producers and non-producers at baseline for Hand grip strength using a calibrated JAMAR® Hydraulic Hand Dynamometer		2 days
Secondary	Differences between UA producers and non-producers at baseline for gait speed using the 4-meter gait speed test		2 days
Secondary	Differences between UA producers and non-producers at baseline for physical activity levels assessed via the International Physical Activity Questionnaire.	Questionnaire consists of questions that provide information on the physical activity in the last 7 days. Activities include total of duration and frequency from walking, moderate activity and severe physical activity. Accordingly,there are 3 activity levels: Inactive,minimal active and very active.The lowest level of physical activity is inactive and the highest level of physical activity is very active.	2 days
Secondary	Differences between UA producers and non-producers at baseline for energy levels assessed via the Lee-Visual Analogue Scale to assess Fatigue (VAS-F).	The scale consists of 18 items relating to the subjective experience of fatigue. Scores fall between 0 (not fatigued at all) and 100 (extremely fatigued).	2 days
Secondary	Differences between UA producers and non-producers at baseline for gut microbiome. Fecal samples will be used to extract DNA and shotgun sequencing will be performed to assess global microbiome differences at the species level.		2 days
Secondary	Differences between UA producers and non-producers at baseline for plasma metabolome. Metabolites in serum will be measured by metabolomic mass spectrometry		2 days
Secondary	Differences between UA producers and non-producers at baseline for blood biochemistry metabolic profile as assessed via lipid profile in plasma.		2 days
Secondary	Differences in consumer perception on the study investigation food products overall taste using a consumer perception Likert scale	Scale, of 1 to 5 where 1 is dislike extremely and 5 is like extremely	1 day